Form D · Biotechnology
BioKier, Inc.
Chapel Hill, NC · CIK 0001469459
Offering snapshot reported Oct 8, 2014 · SEC filing
- Reported sold
- $230K Offering amount: $1M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 23, 2014 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$150,000 → $230,000
- Reported investors3 → 7
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 8, 2014 | Amendment | $230,000 | $80,000vs Aug 4, 2014 | 7 | SEC filing |
| Aug 4, 2014 | Initial | $150,000 | No comparison | 3 | SEC filing |
| Jul 19, 2013 | Initial | $645,000 | No comparison | 1 | SEC filing |
| Jun 7, 2013 | Initial | $40,000 | No comparison | 1 | SEC filing |
| Feb 19, 2013 | Amendment | $340,000 | $115,000vs Sep 14, 2012 | 17 | SEC filing |
| Sep 14, 2012 | Amendment | $225,000 | $175,000vs Sep 26, 2011 | 12 | SEC filing |
| Apr 18, 2012 | Amendment | $155,000 | $50,000vs Mar 15, 2012 | 7 | SEC filing |
| Mar 15, 2012 | Amendment | $105,000 | $55,000vs Sep 26, 2011 | 6 | SEC filing |
| Sep 26, 2011 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Oct 14, 2009 | Amendment | $249,999 | $150,000vs Aug 7, 2009 | 1 | SEC filing |
| Oct 9, 2009 | Amendment | $199,999 | $100,000vs Aug 7, 2009 | 1 | SEC filing |
| Aug 7, 2009 | Initial | $99,999 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-222247
Source: Form D, filed Oct 8, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Farrelly | Director |
| Roger Nolan | Director, Executive |
| Jerzy R Szewczyk | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
105 Green Willow Court
Chapel Hill, NC, 27514
Chapel Hill, NC, 27514